Lo's Lab Readies T21 Test for Hong Kong, Looks to Additional Sequencing-based Prenatal Dx
November 30, 2011
Lo's Lab Readies T21 Test for Hong Kong, Looks to Additional Sequencing-based Prenatal Dx
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Lo Team Finds Targeted, SNP-Based Approach for T21 Detection 'Less Robust' than Shotgun Sequencing
May 30, 2012 / Clinical Sequencing News - Aria Plans Clinical Trial of T21 Dx in 25K Women; Says Test Does Not Infringe Sequenom IP
January 18, 2012 / Clinical Sequencing News - Verinata Licenses Quake Patent, Setting Stage for IP Tussle with Sequenom
September 7, 2011 / Clinical Sequencing News - Quake Group Issued Patent for Detection of Fetal Aneuploidy with Next-Gen Sequencing
August 31, 2011 / Clinical Sequencing News - Building on Trisomy 21 Test, Hong Kong Team Develops Method to Detect T13 and T18
July 6, 2011 / Clinical Sequencing News